Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

7-Hydroxystaurosporine

Generic Name: 7-Hydroxystaurosporine

Drug Type: Small Molecule

Chemical Formula: C_₂₈H_₂₆N_₄O_₄

CAS Number: 112953-11-4

Unique Ingredient Identifier: 7BU5H4V94A

Overview

No overview information available.

Background

No background information available.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

7-Hydroxystaurosporine and Perifosine in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia or High Risk Myelodysplastic Syndromes

Phase 1

Completed

Posted: 2006/03/13

Sponsor:National Cancer Inst...

ID:NCT00301938

7-hydroxystaurosporine and Topotecan Hydrochloride in Treating Patients With Relapsed or Progressed Small Cell Lung Cancer

Phase 2

Completed

Posted: 2004/12/09

Sponsor:National Cancer Inst...

ID:NCT00098956

Cytarabine and UCN-01 in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia or Myelodysplastic Syndrome

Phase 1

Completed

Posted: 2004/07/26

Sponsor:M.D. Anderson Cancer...

ID:NCT00004263

UCN-01 in Treating Patients With Advanced Cancer

Phase 1

Completed

Posted: 2004/05/21

Sponsor:Sidney Kimmel Compre...

ID:NCT00003289

UCN-01 and Topotecan in Treating Patients With Recurrent, Persistent, or Progressive Advanced Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

Phase 2

Completed

Posted: 2003/11/06

Sponsor:University Health Ne...

ID:NCT00072267

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy